Potential Risk of Diabetic Lumbosacral Radiculoplexus Neuropathy (DLSRPN) in Association with Glucagon-like-Peptide-1 (GLP-1) Analog: A Case Series

Reduced Cerebrospinal Fluid Biomarkers (Neurofilament Light Chain, B Cells, T Cells) and Improved Clinical/Imaging Assessments of Disease Activity Are Sustained After 5 Years of Ocrelizumab Treatment: Long-term Extension Results from OBOE

Emergency Department Visit for Fall and the Future Risk of Status Epilepticus